Open Access · CC BY 4.0
Cardiac Amyloidosis and SGLT2 Inhibitors: Signal, Hope, and the Need for Randomized Evidence
Arquivos Brasileiros de Cardiologia · 2026-01 · 123 (1)
DOI: 10.36660/abc.20250894i ↗Kurz gefasst
Fachartikel in der Zeitschrift Arquivos Brasileiros de Cardiologia, 2026-01. Verfasst von Humberto Villacorta und 1 weiteren Autor:innen. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Villacorta, H., & Villacorta, A. S. (2026). Cardiac Amyloidosis and SGLT2 Inhibitors: Signal, Hope, and the Need for Randomized Evidence. Arquivos Brasileiros de Cardiologia, 123(1). https://doi.org/10.36660/abc.20250894i
Vancouver
Villacorta H, Villacorta AS. Cardiac Amyloidosis and SGLT2 Inhibitors: Signal, Hope, and the Need for Randomized Evidence. Arquivos Brasileiros de Cardiologia. 2026;123(1). doi:10.36660/abc.20250894i
BibTeX
@article{Villacorta2026,
author = {Villacorta, Humberto and Villacorta, Aline Sterque},
title = {Cardiac Amyloidosis and SGLT2 Inhibitors: Signal, Hope, and the Need for Randomized Evidence},
journal = {Arquivos Brasileiros de Cardiologia},
year = {2026},
volume = {123},
number = {1},
doi = {10.36660/abc.20250894i}
}
EUVIMED